Publicaciones (69) Publicaciones en las que ha participado algún/a investigador/a

2023

  1. A single-arm study design with non-inferiority and superiority time-to-event endpoints: a tool for proof-of-concept and de-intensification strategies in breast cancer

    Frontiers in Oncology, Vol. 13

  2. Absence of Myocardial Involvement After SARS-CoV-2 Vaccination in Asymptomatic Adolescents

    Journal of Cardiovascular Translational Research

  3. Alopecia en supervivientes de cáncer de mama en tratamiento con terapia hormonal

    Más dermatología, Núm. 42, pp. 11-12

  4. Ambulatory surgery for chronic venous insufficiency using radiofrequency thermoablation: quality and satisfaction

    Cirugia y Cirujanos (English Edition), Vol. 91, Núm. 5, pp. 672-677

  5. Analysis of tumor infiltrating CD4+ and CD8+ CDR3 sequences reveals shared features putatively associated to the anti-tumor immune response

    Frontiers in Immunology, Vol. 14

  6. Association of HER2DX with pathological complete response and survival outcomes in HER2-positive breast cancer

    Annals of Oncology, Vol. 34, Núm. 9, pp. 783-795

  7. Binding Affinity of Trastuzumab and Pertuzumab Monoclonal Antibodies to Extracellular HER2 Domain †

    International Journal of Molecular Sciences, Vol. 24, Núm. 15

  8. Capivasertib in Hormone Receptor-Positive Advanced Breast Cancer

    The New England journal of medicine, Vol. 388, Núm. 22, pp. 2058-2070

  9. Cardiac Safety and Efficacy of SB3 Trastuzumab Biosimilar for ERBB2-Positive Early Breast Cancer: Secondary Analysis of a Randomized Clinical Trial

    JAMA Network Open, Vol. 6, Núm. 4, pp. E235822

  10. Chromatin insulation orchestrates matrix metalloproteinase gene cluster expression reprogramming in aggressive breast cancer tumors

    Molecular Cancer, Vol. 22, Núm. 1

  11. Clinical characterization and treatment outcomes of follicular cutaneous immune–related adverse events caused by immune checkpoint inhibitors: A multicenter retrospective study

    Journal of the American Academy of Dermatology, Vol. 88, Núm. 3, pp. 718-720

  12. Comparative Cardiac Magnetic Resonance-Based Feature Tracking and Deep-Learning Strain Assessment in Patients Hospitalized for Acute Myocarditis

    Journal of Clinical Medicine, Vol. 12, Núm. 3

  13. Correction to: Improving clinical paediatric research and learning from COVID-19: recommendations by the Conect4Children expert advice group (Pediatric Research, (2022), 91, 5, (1069-1077), 10.1038/s41390-021-01587-3)

    Pediatric Research

  14. Cyclin-Dependent Kinase 4/6 Inhibitors and Dermatologic Adverse Events: Results from the EADV Task Force “Dermatology for Cancer Patients” International Study

    Cancers, Vol. 15, Núm. 14

  15. DESTINY-Breast03 trial: some questions remain – Authors' reply

    The Lancet

  16. Detection of novel therapies using a multi-national, multi-institutional registry of cutaneous immune-related adverse events and management

    International Journal of Dermatology, Vol. 62, Núm. 8, pp. 1020-1025

  17. Directional Atherectomy With Antirestenotic Therapy Versus PTA/Supera Stenting for Popliteal Artery Lesions: A Propensity-Matched Analysis

    Journal of Endovascular Therapy

  18. Drug reactions with eosinophilia and systemic symptoms induced by immune checkpoint inhibitors: an international cohort of 13 cases

    Melanoma research, Vol. 33, Núm. 2, pp. 155-158

  19. ER+, HER2− advanced breast cancer treated with taselisib and fulvestrant: genomic landscape and associated clinical outcomes

    Molecular Oncology, Vol. 17, Núm. 10, pp. 2000-2016

  20. ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer

    Annals of Oncology, Vol. 34, Núm. 8, pp. 645-659